CoChat

A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor

Jankovic, J., Schwartz, K., Clemence, W., Aswad, A., Mordaunt, J. · 1996 · Movement Disorders

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Abstract

Twenty‐five patients with hand tremor of 2 + (moderate) to 4 + (severe) on the tremor severity rating scale were randomized to receive either 50 U of botulinum toxin (BTX) type A (Allergan, Irvine, CA) or placebo injections into the wrist flexors and extensors of the dominant limb. If patients failed to respond to the initial injection, they were eligible to receive another injection of 100 U 4 weeks later. Rest, postural, and kinetic tremors were evaluated at 2‐ to 4‐week intervals over a 16‐week study period using tremor severity rating scales, accelerometry, and assessments of improvement and disability. A signigicant improvment (p < 0.05) was observed on the tremor severity rating scale 4 weeks after injection in patients treated with BTX as compared with placebo, and this effect was maintained for the duration of the study. Four weeks after injection, 75% of BTX‐treated patients vs. 27% of placebo‐treated patients (p < 0.05). reported mild to moderate improvement (peak effect rating ≥2). There were no significant improvements in functional rating scales, although trends were observed for some items. Postural accelerometry measurements showed a ≥30% reduction in amplitude in nine of 12 BTX‐treated subjects and in one of nine placebo‐treated subjects (p < 0. 05). Although all patients treated with BTX reported some degree of finger weakness, no severe, irreversible, or unexpected adverse events occurred. Chemodenervation with BTX may significantly ameliorate essential hand tremor in patients who fail to improve with conventional pharmacologic therapy.

Overview

Integrity signals

Registry

Crossref · 10.1002/mds.870110306

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 15 references

Research works printed but not linked: 2

  1. Lou JS, 1991, Current neurology, 199
  2. Ludlow CL, 1989, Treatment of voice tremor with botulinum toxin injection [Abstract], Neurology, 39, 353

Cited by

Items 201–234 of 234

Metadata

Authors
Jankovic, J., Schwartz, K., Clemence, W., Aswad, A., & Mordaunt, J.
Affiliations
Baylor College of Medicine (US)
Corresponding author
Jankovic, J.
Venue
Movement Disorders
Publisher
Wiley
Published
1996-05
Volume
11
Issue
3
Pages
250-256
ISSN
  • 0885-3185 (ISSN-L)
  • 1531-8257
OpenAlex
W2010076187
Cited by
235
References
15
Citations by year
2026: 9 · 2025: 8 · 2024: 9 · 2023: 7 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 8 · 2018: 9 · 2017: 12 · 2016: 10 · 2015: 7 · 2014: 5 · 2013: 8 · 2012: 10
FWCI
2.57
Type
journal article
Language
en
Open access
closed
Locations
  • Movement Disorders (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Botulinum Toxin and Related Neurological Disorders
  • Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
  • Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
Keywords
botulinum toxin type A, wrist flexors, wrist extensors, accelerometry, postural tremor, kinetic tremor, chemodenervation
MeSH terms
Aged, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Electromyography, Female, Hand, Humans, Injections, Intramuscular, Male, Middle Aged, Motor Skills, Neurologic Examination, Signal Processing, Computer-Assisted, Tremor, Treatment Outcome, Botulinum Toxins, Type A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.